Evidence map›Paper›PMID 40764316›Full record

ArticleNature communications2025

FGF receptor modulates planar cell polarity in the neuroectoderm via Vangl2 tyrosine phosphorylation.

Ilya Chuykin, Sergei Y Sokol

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Deubiquitination of Vangl by USP6 and USP32 Regulates Planar Cell Polarity Signaling.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  3. Article
  4. Linking Planar Cell Polarity to Mechanotransduction During Morphogenesis.BioEssays : news and reviews in molecular, cellular and developmental biology · 2026
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Ilya ChuykinDepartment of Cell, Developmental and Regenerative Biology, Icahn School of Medicine at Mount Sinai, New York, USA.
Sergei Y SokolDepartment of Cell, Developmental and Regenerative Biology, Icahn School of Medicine at Mount Sinai, New York, USA. sergei.sokol@mssm.edu.ORCID http://orcid.org/0000-0002-3963-9202

Funding

Regulation of cell polarity by Wnt signalingR35GM122492 · NIGMS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Sergei Sokol · 2017 to 2026
$5.0M
Extracellular regulation of Xenopus developmentR01HD092990 · NICHD · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Sergei Sokol · 2018 to 2026
$3.2M
NICHD NIH HHS R01 HD092990NIGMS NIH HHS R35 GM122492U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) R35GM122492
6 · The paper itself

Abstract

FGF receptors play pivotal roles in morphogenetic processes, including vertebrate neurulation. Planar cell polarity signaling coordinates cell orientation in the tissue plane and is essential for neural tube closure. Here, we demonstrate abnormal planar polarity in the Xenopus neuroectoderm depleted of FGFR1, suggesting a mechanistic connection between FGFR signaling and morphogenesis. FGFR1 associates with the core planar cell polarity protein Vangl2, leading to its phosphorylation at N-terminal tyrosines, a modification also induced by FGF8. Vangl2 phosphorylation requires FGFR1 activity in Xenopus embryos and mouse embryonic stem cells, extending our observations to mammals. A non-phosphorylatable Vangl2 construct exhibits increased binding to the receptor tyrosine kinase PTK7, suggesting a potential role of Vangl2 phosphorylation. By contrast, a phosphomimetic Vangl2 mutant shows reduced interactions with Prickle and PTK7, and disrupted planar polarity in the neuroectoderm. Together, these findings identify cross-talk between the FGFR1 and planar cell polarity pathways mediated by Vangl2 tyrosine phosphorylation.

Indexed as

Cell PolarityMembrane ProteinsNerve Tissue ProteinsNeural PlateReceptor, Fibroblast Growth Factor, Type 1Xenopus ProteinsAnimalsFibroblast Growth Factor 8HumansLIM Domain ProteinsMiceMouse Embryonic Stem CellsPhosphorylationReceptor Protein-Tyrosine KinasesSignal TransductionTyrosineFibroblast Growth Factor 8LIM Domain ProteinsLtap protein, mouseMembrane ProteinsNerve Tissue ProteinsPtk7 protein, mousePTK7 protein, XenopusReceptor, Fibroblast Growth Factor, Type 1Receptor Protein-Tyrosine KinasesTyrosineXenopus Proteins

Identifiers

PMID40764316
PMCPMC12326008

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.